ATAI
Price
$2.17
Change
+$0.06 (+2.84%)
Updated
Jun 25, 12:49 PM (EDT)
Capitalization
444.67M
54 days until earnings call
QNTM
Price
$24.23
Change
-$2.90 (-10.69%)
Updated
Jun 25, 01:15 PM (EDT)
Capitalization
78.29M
Interact to see
Advertisement

ATAI vs QNTM

Header iconATAI vs QNTM Comparison
Open Charts ATAI vs QNTMBanner chart's image
ATAI Life Sciences
Price$2.17
Change+$0.06 (+2.84%)
Volume$478
Capitalization444.67M
Quantum Biopharma
Price$24.23
Change-$2.90 (-10.69%)
Volume$331
Capitalization78.29M
ATAI vs QNTM Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. QNTM commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and QNTM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ATAI: $2.11 vs. QNTM: $27.13)
Brand notoriety: ATAI and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 132% vs. QNTM: 234%
Market capitalization -- ATAI: $444.67M vs. QNTM: $78.29M
ATAI [@Biotechnology] is valued at $444.67M. QNTM’s [@Biotechnology] market capitalization is $78.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while QNTM’s TA Score has 2 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • QNTM’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than QNTM.

Price Growth

ATAI (@Biotechnology) experienced а -4.95% price change this week, while QNTM (@Biotechnology) price change was +5.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.26%. For the same industry, the average monthly price growth was +35.95%, and the average quarterly price growth was +19.76%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

QNTM is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+4.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($445M) has a higher market cap than QNTM($78.3M). QNTM YTD gains are higher at: 637.228 vs. ATAI (58.647). QNTM has higher annual earnings (EBITDA): -20.68M vs. ATAI (-145.09M). ATAI has more cash in the bank: 98.2M vs. QNTM (3.54M). QNTM has less debt than ATAI: QNTM (1.28M) vs ATAI (26.7M). ATAI has higher revenues than QNTM: ATAI (1.86M) vs QNTM (0).
ATAIQNTMATAI / QNTM
Capitalization445M78.3M568%
EBITDA-145.09M-20.68M702%
Gain YTD58.647637.2289%
P/E RatioN/AN/A-
Revenue1.86M0-
Total Cash98.2M3.54M2,775%
Total Debt26.7M1.28M2,086%
FUNDAMENTALS RATINGS
ATAI vs QNTM: Fundamental Ratings
ATAI
QNTM
OUTLOOK RATING
1..100
6724
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
12n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (65) in the Miscellaneous Commercial Services industry is in the same range as QNTM (73) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's Profit vs Risk Rating (97) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as ATAI (35) in the Miscellaneous Commercial Services industry. This means that QNTM’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's P/E Growth Rating (13) in the Miscellaneous Commercial Services industry is significantly better than the same rating for QNTM (100) in the null industry. This means that ATAI’s stock grew significantly faster than QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIQNTM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CICHY20.460.57
+2.87%
China Construction Bank Corp.
SYHBF0.250.01
+2.69%
Skyharbour Resources Ltd.
BRDCY20.540.19
+0.93%
Bridgestone Corp.
SGPYY68.94-0.02
-0.03%
Sage Group plc (The)
LTGHY3.17-0.03
-1.09%
Life Healthcare Group Holdings Ltd

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+4.46%
MNMD - ATAI
54%
Loosely correlated
+7.52%
CRSP - ATAI
46%
Loosely correlated
+2.70%
RXRX - ATAI
46%
Loosely correlated
+8.07%
CYBN - ATAI
46%
Loosely correlated
+5.80%
COUR - ATAI
45%
Loosely correlated
+1.78%
More

QNTM and

Correlation & Price change

A.I.dvisor tells us that QNTM and CPIX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNTM and CPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+17.91%
CPIX - QNTM
26%
Poorly correlated
-16.03%
EBS - QNTM
24%
Poorly correlated
+3.83%
PBH - QNTM
24%
Poorly correlated
+0.33%
ATAI - QNTM
24%
Poorly correlated
+4.46%
INCR - QNTM
23%
Poorly correlated
-2.58%
More